Immune support capsules to be tested against COVID-19 – Montreal Heart Institute study

According to the press release, the study is designed to “evaluate the effect of hesperidin on COVID-19 symptoms and its ability to reduce disease severity and the need for hospitalization in patients with COVID-19. The randomized, double-blind, placebo-controlled study will enroll 216 confirmed COVID-19 symptomatic patients.

The release continues;

“The immune support properties of hesperidin, the medicinal ingredient contained in HESPERCO™ capsules, and its efficacy against other coronavirus strains are well documented in scientific literature.” If you type in Hesperidin on ScienceDirect, a medical journal sharing website – you will get many different articles discussing the potential benefits of Hesperidin.

One of the medical journals discussing Hesperidin is titled “Polyphenols in the Prevention and Treatment of Vascular and Cardiac Disease, and Cancer” and discusses the trials that have shown the beneficial effects of hesperidin.

In the abstract is says ” Hesperidin exhibits several pharmacological actions such as antihyperlipidemic, cardioprotective, antihypertensiveantidiabetic activities, which are mainly attributed to an antioxidant defence mechanism and suppression of pro-inflammatory cytokine production.”

It continues;

Various randomized crossover trials have shown the beneficial effects of hesperidin, which mainly results from anti-inflammatory and anti-atherogenic actions.

I suppose the question that comes to mind is if various randomized crossover trials have shown the beneficial effects of Hesperidin in regards to anti-inflammatory actions – why didn’t we test it against Covid-19 sooner? Hesperidin has already shown pharmacological actions that are attributed “to an antioxidant defence mechanism and suppression of pro-inflammatory cytokine production” – a major issue in severe Covid-19 cases.

Aim of the study

The trial, run by The Montreal Heart Institute says “The main aim of this study is to determine the effects of short-term treatment with hesperidin on COVID-19 symptoms in comparison with a placebo.” The release says the “treatment effects will be observed through a symptoms diary that will be completed by participants throughout the study and by taking the oral temperature daily.”

Ingenew Pharma will be observing if hesperidin can reduce the severity of illness as well as seeing if hesperidin can reduce the requirement for hospitalization.


You can learn more about Hesperco, the product derived from Hesperidin on their website. What is Hesperidin though? Hesperidin is a major flavonoid found in lemons and sweet oranges as well as in some other fruits and vegetables.”

A bottle comes with 60 capsules and will cost you $33.89 – plus shipping of course. Although it is unclear if Hesperidin will help in the fight against Covid-19 – boosting your immune system naturally or through a product like Hesperco just makes good sense in regards to overall health. Each capsule contains 500mg of Hesperidin.

Diverge Media is an independent Canadian media outlet dedicated to bringing you the stories that matter. We do not, and will not ever accept government funding for our work. Therefore, we rely entirely on the donations and purchases of our readers/viewers. If you would like to support more independent stories like this, you can do so by buying a hat on our online store – or by donating in the form below! All the best – the Diverge Media team.

Diverge Media Donation

Personal Info

Donate quickly and securely with Stripe

How it works: A Stripe window will open after you click the Donate Now button where you can securely make your donation. You will then be brought back to this page to view your receipt.

Diverge Media Donation

Donation Total: $50.00

Photo by Belinda Fewings on Unsplash

Published by Greg Staley

Greg Staley is a husband and a father to 4 beautiful girls. He is the owner of Diverge Media and takes pride in telling the stories that matter - even if they may be unpopular. In addition to writing, editing, and producing videos and articles for Diverge, Mr. Staley also works full-time on a farm. Mr. Staley is working hard to be able to pursue Diverge Media full-time and wholeheartedly believes that it will become a reality in the near-future with the support of the readers/viewers of Diverge Media.